BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1378322)

  • 1. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
    Kita K; Nakase K; Miwa H; Masuya M; Nishii K; Morita N; Takakura N; Otsuji A; Shirakawa S; Ueda T
    Blood; 1992 Jul; 80(2):470-7. PubMed ID: 1378322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
    Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
    Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma.
    Kita K; Shirakawa S; Kamada N
    Leuk Lymphoma; 1994 Apr; 13(3-4):229-34. PubMed ID: 8049646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are some cases of acute leukemia with t(8;21) hybrid leukemias?
    Sun GX; Sparkes RS; Wormsley S; Naeim F; Champlin R; Gale RP
    Cancer Genet Cytogenet; 1990 Oct; 49(2):177-84. PubMed ID: 2170002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].
    Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
    Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
    Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
    Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
    Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
    Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
    Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin.
    Miwa H; Mizutani M; Mahmud N; Yamaguchi M; Takahashi T; Shikami M; Shiku H; Tanaka I; Nakase K; Nasu K; Dohy H; Ueda T; Kamada N; Kita K
    Leukemia; 1998 Jan; 12(1):44-51. PubMed ID: 9436919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
    Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
    Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
    Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
    Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction.
    Wittebol S; Raymakers R; van de Locht L; Mensink E; de Witte T
    Leukemia; 1998 Nov; 12(11):1782-8. PubMed ID: 9823954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
    Khoury H; Dalal BI; Nevill TJ; Horsman DE; Barnett MJ; Shepherd JD; Toze CL; Conneally EA; Sutherland HJ; Hogge DE; Nantel SH
    Leuk Lymphoma; 2003 Oct; 44(10):1713-8. PubMed ID: 14692523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).
    García Vela JA; Martin M; Delgado I; García Alonso L; Monteserin MC; Benito L; Somolinos N; Oña F
    Ann Hematol; 1999 May; 78(5):237-40. PubMed ID: 10391105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501.
    Weidmann E; Brieger J; Karakas T; Maurer U; Pascheberg U; Hoelzer D; Mitrou PS; Bergmann L
    Leukemia; 1997 May; 11(5):709-13. PubMed ID: 9180296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.